Congress OKs Last-Minute Fix To Save $250M In FDA Fees

Law360, New York (September 24, 2012, 3:56 PM EDT) -- In a last-minute bid to save $250 million in U.S. Food and Drug Administration user fees from slipping out of the agency's grasp, the Senate approved a bill early Saturday morning that will allow the FDA to collect new generic-drug user fees starting Oct. 1.

A glitch in the user fee bill, known as the FDA Safety and Innovation Act, combined with Congress' decision to use a continuing resolution to fund the government for the next six months, would have prevented the FDA from getting most...
To view the full article, register now.